## Note
nid: 1483844994929
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Neurology::Neuro_Misc, #AK_Step1_v11::#FirstAid::12_Neuro_&_Special_Senses::02_Anatomy_&_Physiology::19_Dopaminergic_Pathways, #AK_Step1_v11::#FirstAid::12_Neuro_&_Special_Senses::02_Anatomy_&_Physiology::19_Dopaminergic_Pathways::Mesocortical, #AK_Step1_v11::#OME_banner::Clinical::10_Neurology, #AK_Step1_v11::^Systems::Neuro::neurology, #AK_Step1_v11::^Systems::Neuro::neuroscience
markdown: false

### Text
<div>
  Are <i>1st-generation</i> <u>anti-psychotic drugs</u> effective
  at reducing the "<b>negative</b> <b>symptoms</b>" associated with
  <b>schizophrenia</b>?
</div>
<div>
  {{c1::No (limited effect)}}
</div>

### Extra
<i>negative symptoms are associated with <u>blockage</u> of the
mesocortical pathway</i>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<img src="tmpYGim8Z.png">

### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/neurology?ref=anki"><img src="_OME_AnkiFlashcards_Topic_1.png"></a>
</div>

### Additional Resources


### One by one

